3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
8
Endometrial Neoplasms
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sexual Dysfunctions, Psychological
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Carcinoma
1
Interventions
pembrolizumab
12
Cisplatin
5
Cetuximab
5
Paclitaxel
4
durvalumab
3
Nivolumab
3
Ipilimumab
3
Gemcitabine
3
Cyclophosphamide
3
poly ICLC
2
avelumab
2
Radiation
2
Pemetrexed
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
Carboplatin
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
vistusertib
1
tislelizumab
1
tirbanibulin
1
spartalizumab
1
sonidegib
1
sitravatinib
1
repotrectinib
1
pralsetinib
1
pertuzumab
1
pepinemab
1
obinutuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Carcinoma
×
Anastrozole
×
Clear all
NCT02730923
2024-02-13
VICTORIA
Centre Leon Berard
Phase 1/2
Unknown
72 enrolled